AU2001230533A1 - Powdered preparation for inhalation and powder inhalant containing the same packed - Google Patents

Powdered preparation for inhalation and powder inhalant containing the same packed

Info

Publication number
AU2001230533A1
AU2001230533A1 AU2001230533A AU3053301A AU2001230533A1 AU 2001230533 A1 AU2001230533 A1 AU 2001230533A1 AU 2001230533 A AU2001230533 A AU 2001230533A AU 3053301 A AU3053301 A AU 3053301A AU 2001230533 A1 AU2001230533 A1 AU 2001230533A1
Authority
AU
Australia
Prior art keywords
inhalation
powdered preparation
powder inhalant
same packed
inhalant containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230533A
Inventor
Kazuhiko Ikegami
Den-Ichi Momose
Yasuhiro Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Publication of AU2001230533A1 publication Critical patent/AU2001230533A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001230533A 2000-02-04 2001-01-31 Powdered preparation for inhalation and powder inhalant containing the same packed Abandoned AU2001230533A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-27534 2000-02-04
JP2000027534 2000-02-04
PCT/JP2001/000627 WO2001056581A1 (en) 2000-02-04 2001-01-31 Powdered preparation for inhalation and powder inhalant containing the same packed

Publications (1)

Publication Number Publication Date
AU2001230533A1 true AU2001230533A1 (en) 2001-08-14

Family

ID=18553094

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230533A Abandoned AU2001230533A1 (en) 2000-02-04 2001-01-31 Powdered preparation for inhalation and powder inhalant containing the same packed

Country Status (2)

Country Link
AU (1) AU2001230533A1 (en)
WO (1) WO2001056581A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10338399A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Microparticles containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1H) -oxoquinazolin-3-yl) -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyridinyl) -piperazine, process for their preparation and their use as inhalation powder
DE10338407A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg New inhalable powders containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1H) -oxoquinazolin-3-yl) -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyridinyl) -piperazine
DE10338402A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried, amorphous BIBN 4096, process for its preparation and its use as inhalant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US5635160A (en) * 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5789391A (en) * 1996-07-03 1998-08-04 Inspire Pharmaceuticals, Inc. Method of treating sinusitis with uridine triphosphates and related compounds
PT1012154E (en) * 1997-07-25 2004-08-31 Inspire Pharmaceuticals Inc METHOD FOR PREPARING THE METHOD FOR PREPARATION, AND THEIR UTILIZATIONS

Also Published As

Publication number Publication date
WO2001056581A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
AU1409801A (en) Powder inhaler
HUP0200818A2 (en) Powder inhaler for combined medicament
AU2001233201A1 (en) Dry powder inhaler
EG24139A (en) New inhalable powder containing tiotropium
EG24478A (en) New inhalable powder containing tiotropium
HUP0200855A2 (en) Powder inhaler for combined medicament
GB0115520D0 (en) De-agglomerator for breath-actuated dry powder inhaler
HUP0300593A3 (en) Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
AU9043201A (en) Continuous dry powder inhaler
AU2002361453A1 (en) Metered dose inhaler
HK1068007A1 (en) Powder inhaler
HUP0002538A3 (en) Inhaler for powdered medicaments
AU2002311213A1 (en) Dry powder inhalation system for transpulmonary administration
AU2002333644A1 (en) Dry powder medicament formulations
IL141124A0 (en) Two-piece capsule for receiving pharmaceutical preperations for powder inhalers
AU2001257034A1 (en) Compressed gas dry powder inhaler
GB9826783D0 (en) Inhalation powders
AU2001254924A1 (en) Powders for use in a dry powder inhaler
AU4803500A (en) Aerosol inhalation device providing improved aerosol delivery
HUP0003207A3 (en) Proliposome powders for inhalation stabilised by tocopherol, pharmaceutical compositions containing the same and the use of them
GB0003935D0 (en) Formulation for dry powder inhaler
AU4417101A (en) Metered dose inhaler
AU2001256168A1 (en) Metered dose inhaler
AU2001258550A1 (en) Insulin formulation for inhalation
AU4831801A (en) Metered dose inhaler